Satoshi Kashiwagi, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lasers | 7 | 2022 | 949 | 1.630 |
Why?
|
| Adjuvants, Immunologic | 8 | 2022 | 999 | 1.520 |
Why?
|
| Infrared Rays | 6 | 2022 | 249 | 1.490 |
Why?
|
| Nitric Oxide | 13 | 2022 | 2132 | 1.380 |
Why?
|
| Nitric Oxide Synthase Type III | 8 | 2022 | 689 | 1.380 |
Why?
|
| Lasers, Semiconductor | 2 | 2020 | 46 | 1.300 |
Why?
|
| Vaccines | 6 | 2021 | 823 | 1.250 |
Why?
|
| Influenza Vaccines | 5 | 2022 | 738 | 1.120 |
Why?
|
| Vaccination | 5 | 2020 | 3275 | 1.020 |
Why?
|
| Injections, Intradermal | 3 | 2018 | 117 | 0.780 |
Why?
|
| Dendritic Cells | 5 | 2018 | 2720 | 0.720 |
Why?
|
| Skin | 4 | 2018 | 4372 | 0.590 |
Why?
|
| Fluorescent Dyes | 10 | 2023 | 1903 | 0.510 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2023 | 717 | 0.510 |
Why?
|
| Nanoparticles | 3 | 2022 | 1898 | 0.470 |
Why?
|
| Mast Cells | 2 | 2018 | 1544 | 0.420 |
Why?
|
| Laser Therapy | 1 | 2018 | 1071 | 0.400 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2013 | 247 | 0.390 |
Why?
|
| Cyclobutanes | 2 | 2022 | 59 | 0.390 |
Why?
|
| Sulfonic Acids | 2 | 2021 | 97 | 0.370 |
Why?
|
| Influenza A virus | 1 | 2013 | 457 | 0.360 |
Why?
|
| Quaternary Ammonium Compounds | 2 | 2021 | 204 | 0.350 |
Why?
|
| Serine | 1 | 2013 | 825 | 0.330 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4477 | 0.330 |
Why?
|
| Mice | 32 | 2023 | 81154 | 0.310 |
Why?
|
| Animals | 44 | 2023 | 168660 | 0.290 |
Why?
|
| Tissue Distribution | 5 | 2023 | 2327 | 0.270 |
Why?
|
| Melanoma, Experimental | 2 | 2009 | 560 | 0.270 |
Why?
|
| Reactive Oxygen Species | 4 | 2022 | 2077 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 13 | 2020 | 21824 | 0.250 |
Why?
|
| Neoplasms | 7 | 2023 | 21675 | 0.240 |
Why?
|
| Cells, Cultured | 7 | 2022 | 19232 | 0.240 |
Why?
|
| Fetal Distress | 1 | 2003 | 40 | 0.230 |
Why?
|
| Fluorescein | 2 | 2006 | 171 | 0.230 |
Why?
|
| Heart Rate, Fetal | 1 | 2003 | 75 | 0.220 |
Why?
|
| Adiposity | 1 | 2013 | 1806 | 0.220 |
Why?
|
| Gases | 1 | 2003 | 197 | 0.220 |
Why?
|
| T-Lymphocytes | 2 | 2020 | 10179 | 0.210 |
Why?
|
| Venules | 1 | 2002 | 165 | 0.210 |
Why?
|
| Microcirculation | 3 | 2003 | 1287 | 0.210 |
Why?
|
| Succinimides | 1 | 2021 | 79 | 0.200 |
Why?
|
| Arterioles | 1 | 2002 | 254 | 0.200 |
Why?
|
| Ovarian Neoplasms | 4 | 2022 | 4839 | 0.190 |
Why?
|
| Chemokine CXCL12 | 2 | 2015 | 465 | 0.190 |
Why?
|
| Phosphorylation | 5 | 2022 | 8436 | 0.180 |
Why?
|
| Phenols | 2 | 2022 | 496 | 0.180 |
Why?
|
| Electron Transport Complex IV | 1 | 2020 | 189 | 0.180 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2003 | 333 | 0.180 |
Why?
|
| Serum | 1 | 2020 | 214 | 0.170 |
Why?
|
| Ovalbumin | 2 | 2019 | 719 | 0.170 |
Why?
|
| Insulin Resistance | 1 | 2013 | 3863 | 0.170 |
Why?
|
| Ionophores | 3 | 2023 | 107 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2022 | 2504 | 0.160 |
Why?
|
| Ions | 1 | 2019 | 265 | 0.160 |
Why?
|
| Silicon Dioxide | 1 | 2019 | 213 | 0.160 |
Why?
|
| Nitric Oxide Synthase | 4 | 2006 | 915 | 0.160 |
Why?
|
| Neoplasms, Experimental | 3 | 2008 | 1272 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 4 | 2007 | 2638 | 0.150 |
Why?
|
| Antigen-Presenting Cells | 2 | 2019 | 972 | 0.150 |
Why?
|
| Mannose-Binding Lectins | 1 | 2017 | 100 | 0.150 |
Why?
|
| Oxidation-Reduction | 1 | 2022 | 2183 | 0.140 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15142 | 0.140 |
Why?
|
| Receptors, CCR2 | 1 | 2017 | 212 | 0.140 |
Why?
|
| Peritoneal Neoplasms | 1 | 2022 | 665 | 0.140 |
Why?
|
| Immunization | 2 | 2018 | 1255 | 0.130 |
Why?
|
| Cell Movement | 2 | 2018 | 5216 | 0.130 |
Why?
|
| Carotid Artery Diseases | 1 | 2021 | 875 | 0.130 |
Why?
|
| Endothelium, Vascular | 3 | 2006 | 4459 | 0.130 |
Why?
|
| Endothelial Cells | 3 | 2022 | 3482 | 0.120 |
Why?
|
| Signal Transduction | 4 | 2022 | 23398 | 0.120 |
Why?
|
| Cell Separation | 1 | 2020 | 1750 | 0.120 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 1181 | 0.120 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 589 | 0.120 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2022 | 1017 | 0.110 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 715 | 0.110 |
Why?
|
| Alginates | 1 | 2015 | 252 | 0.110 |
Why?
|
| Lymph Nodes | 2 | 2019 | 3476 | 0.110 |
Why?
|
| Russia | 1 | 2014 | 408 | 0.110 |
Why?
|
| Glioma | 1 | 2008 | 3401 | 0.110 |
Why?
|
| Antigens, Surface | 1 | 2017 | 1663 | 0.110 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 435 | 0.110 |
Why?
|
| Biological Availability | 2 | 2023 | 397 | 0.110 |
Why?
|
| Contrast Media | 2 | 2023 | 5301 | 0.110 |
Why?
|
| Rats, Wistar | 6 | 2006 | 1892 | 0.110 |
Why?
|
| Immunotherapy | 3 | 2022 | 4437 | 0.110 |
Why?
|
| omega-N-Methylarginine | 3 | 2009 | 111 | 0.100 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2014 | 403 | 0.100 |
Why?
|
| Lung Neoplasms | 3 | 2023 | 13112 | 0.100 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 418 | 0.100 |
Why?
|
| Flow Cytometry | 2 | 2017 | 5973 | 0.100 |
Why?
|
| Immunocompetence | 1 | 2011 | 136 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 2 | 2009 | 1351 | 0.090 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2021 | 1518 | 0.090 |
Why?
|
| Vascular Resistance | 1 | 2013 | 936 | 0.090 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2015 | 745 | 0.090 |
Why?
|
| HIV Antigens | 1 | 2009 | 347 | 0.080 |
Why?
|
| Hyperlipidemias | 1 | 2013 | 789 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 13691 | 0.080 |
Why?
|
| Mesothelioma | 1 | 2014 | 818 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2008 | 170 | 0.080 |
Why?
|
| Liver | 4 | 2004 | 7479 | 0.080 |
Why?
|
| Humans | 25 | 2023 | 743811 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2020 | 10477 | 0.070 |
Why?
|
| Fibrosarcoma | 1 | 2009 | 345 | 0.070 |
Why?
|
| Vascular Diseases | 2 | 2013 | 1161 | 0.070 |
Why?
|
| Catechin | 1 | 2007 | 66 | 0.070 |
Why?
|
| Mice, Knockout | 5 | 2013 | 14563 | 0.070 |
Why?
|
| Calcium | 1 | 2020 | 5755 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2018 | 2961 | 0.070 |
Why?
|
| Models, Biological | 2 | 2019 | 9582 | 0.070 |
Why?
|
| Antipyrine | 1 | 2006 | 40 | 0.070 |
Why?
|
| Receptors, CXCR4 | 1 | 2011 | 727 | 0.070 |
Why?
|
| Cancer Vaccines | 1 | 2014 | 1023 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 2013 | 1360 | 0.070 |
Why?
|
| Enzyme Inhibitors | 4 | 2005 | 3794 | 0.070 |
Why?
|
| Free Radical Scavengers | 1 | 2006 | 216 | 0.060 |
Why?
|
| Pregnancy Proteins | 1 | 2006 | 229 | 0.060 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2009 | 952 | 0.060 |
Why?
|
| Mice, Nude | 4 | 2019 | 3680 | 0.060 |
Why?
|
| Radiation Tolerance | 1 | 2007 | 486 | 0.060 |
Why?
|
| Female | 13 | 2022 | 380020 | 0.060 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 18027 | 0.060 |
Why?
|
| Crosses, Genetic | 3 | 2013 | 791 | 0.060 |
Why?
|
| Kupffer Cells | 1 | 2004 | 141 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2007 | 2718 | 0.060 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2022 | 50 | 0.050 |
Why?
|
| Lymphatic System | 1 | 2004 | 252 | 0.050 |
Why?
|
| Splanchnic Circulation | 1 | 2002 | 110 | 0.050 |
Why?
|
| Guanylate Cyclase | 1 | 2003 | 201 | 0.050 |
Why?
|
| Cell Growth Processes | 3 | 2009 | 399 | 0.050 |
Why?
|
| Weight Gain | 1 | 2013 | 2294 | 0.050 |
Why?
|
| Vitamin E | 1 | 2007 | 868 | 0.050 |
Why?
|
| Brain | 3 | 2019 | 26345 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 8035 | 0.050 |
Why?
|
| Uterine Hemorrhage | 1 | 2003 | 255 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2014 | 3690 | 0.050 |
Why?
|
| Drug Delivery Systems | 2 | 2023 | 2217 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2008 | 1537 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2004 | 560 | 0.050 |
Why?
|
| Antibodies | 2 | 2020 | 2459 | 0.050 |
Why?
|
| Glucose | 1 | 2013 | 4398 | 0.050 |
Why?
|
| Ferrosoferric Oxide | 1 | 2021 | 358 | 0.050 |
Why?
|
| Rats | 6 | 2006 | 24250 | 0.040 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 3583 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2004 | 671 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2020 | 561 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2013 | 8551 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2013 | 3264 | 0.040 |
Why?
|
| Half-Life | 1 | 2019 | 660 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 2419 | 0.040 |
Why?
|
| Skull | 1 | 2023 | 812 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2021 | 567 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2002 | 1728 | 0.040 |
Why?
|
| Protoporphyrins | 2 | 1995 | 164 | 0.040 |
Why?
|
| Heme Oxygenase (Decyclizing) | 2 | 1995 | 171 | 0.040 |
Why?
|
| Gelatin | 1 | 2019 | 226 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2019 | 2253 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2022 | 2556 | 0.040 |
Why?
|
| Nanomedicine | 1 | 2019 | 302 | 0.040 |
Why?
|
| Male | 13 | 2021 | 349776 | 0.040 |
Why?
|
| Fluorescence | 1 | 2019 | 752 | 0.040 |
Why?
|
| Tail | 2 | 2009 | 97 | 0.040 |
Why?
|
| Electric Conductivity | 1 | 1997 | 410 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 9731 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 2029 | 0.030 |
Why?
|
| Oxygen | 1 | 2008 | 4189 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2018 | 892 | 0.030 |
Why?
|
| Photosensitizing Agents | 1 | 2020 | 602 | 0.030 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 491 | 0.030 |
Why?
|
| Gap Junctions | 1 | 1997 | 233 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2019 | 1654 | 0.030 |
Why?
|
| Particle Size | 1 | 2019 | 1639 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 1013 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 2692 | 0.030 |
Why?
|
| Hexuronic Acids | 1 | 2015 | 144 | 0.030 |
Why?
|
| Glucuronic Acid | 1 | 2015 | 148 | 0.030 |
Why?
|
| Ischemia | 1 | 2004 | 1907 | 0.030 |
Why?
|
| Carcinoma | 1 | 2007 | 2375 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2005 | 1880 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2006 | 3082 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 3510 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 1374 | 0.030 |
Why?
|
| Molecular Imaging | 1 | 2021 | 821 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 1997 | 964 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2008 | 16674 | 0.030 |
Why?
|
| Potassium Channels | 1 | 1997 | 563 | 0.030 |
Why?
|
| Electrophysiology | 1 | 1997 | 1297 | 0.030 |
Why?
|
| Systems Biology | 1 | 2017 | 470 | 0.030 |
Why?
|
| Hydrogels | 1 | 2019 | 727 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 1997 | 1137 | 0.030 |
Why?
|
| Mutation | 3 | 2013 | 29777 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2015 | 6380 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2019 | 3130 | 0.030 |
Why?
|
| Calcium Channels | 1 | 1997 | 622 | 0.030 |
Why?
|
| tau Proteins | 1 | 2023 | 1869 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2017 | 63042 | 0.030 |
Why?
|
| Carbon Monoxide | 1 | 1995 | 531 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 956 | 0.030 |
Why?
|
| Ion Channels | 1 | 1997 | 1056 | 0.030 |
Why?
|
| Gene Expression | 1 | 2005 | 7793 | 0.030 |
Why?
|
| ROC Curve | 1 | 2019 | 3527 | 0.030 |
Why?
|
| HIV-1 | 1 | 2009 | 6939 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3547 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 1608 | 0.020 |
Why?
|
| Neutrophils | 1 | 2003 | 3718 | 0.020 |
Why?
|
| Stroke | 1 | 2013 | 9975 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2018 | 8316 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2004 | 5021 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1994 | 1150 | 0.020 |
Why?
|
| Regeneration | 1 | 2019 | 1486 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2013 | 476 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2020 | 5445 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 3587 | 0.020 |
Why?
|
| Cell Communication | 1 | 1997 | 1621 | 0.020 |
Why?
|
| Mitochondria | 1 | 2022 | 3513 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 11729 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 2009 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2017 | 1058 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 11360 | 0.020 |
Why?
|
| Apoptosis | 3 | 2011 | 9718 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2009 | 126 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2009 | 429 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2009 | 118 | 0.020 |
Why?
|
| Transfection | 2 | 2007 | 5892 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 644 | 0.020 |
Why?
|
| Peptides | 1 | 2020 | 4406 | 0.020 |
Why?
|
| Lymphangiogenesis | 1 | 2009 | 173 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 2715 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 1436 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 2177 | 0.020 |
Why?
|
| Macrophages | 1 | 2021 | 5651 | 0.020 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2007 | 117 | 0.020 |
Why?
|
| Radiation-Protective Agents | 1 | 2007 | 90 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1656 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 4777 | 0.020 |
Why?
|
| Electrochemistry | 1 | 2006 | 145 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 547 | 0.020 |
Why?
|
| Mesenteric Veins | 1 | 2006 | 89 | 0.020 |
Why?
|
| United States | 1 | 2014 | 69859 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2007 | 964 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 627 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2006 | 462 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 1802 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2006 | 409 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2009 | 1402 | 0.020 |
Why?
|
| Thromboxanes | 1 | 2004 | 50 | 0.020 |
Why?
|
| Dimerization | 1 | 2006 | 894 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 6620 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3874 | 0.010 |
Why?
|
| Kidney | 1 | 2019 | 7185 | 0.010 |
Why?
|
| Fluoresceins | 1 | 2004 | 235 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2004 | 156 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 2009 | 1283 | 0.010 |
Why?
|
| Lymphography | 1 | 2004 | 201 | 0.010 |
Why?
|
| Ligation | 1 | 2004 | 452 | 0.010 |
Why?
|
| Rheology | 1 | 2004 | 345 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 6895 | 0.010 |
Why?
|
| Bile | 1 | 2004 | 299 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 2732 | 0.010 |
Why?
|
| AIDS Vaccines | 1 | 2009 | 938 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2004 | 534 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2006 | 798 | 0.010 |
Why?
|
| RNA Interference | 1 | 2011 | 2890 | 0.010 |
Why?
|
| Bilirubin | 1 | 2004 | 425 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4749 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2007 | 1758 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2007 | 1356 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2009 | 5179 | 0.010 |
Why?
|
| Glutathione | 1 | 2004 | 590 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 29140 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9440 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 2924 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2014 | 10251 | 0.010 |
Why?
|
| Perfusion | 2 | 1995 | 1359 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2004 | 771 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6356 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 1962 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 20827 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2938 | 0.010 |
Why?
|
| Wound Healing | 1 | 2009 | 2776 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 13809 | 0.010 |
Why?
|
| DNA Damage | 1 | 2007 | 2429 | 0.010 |
Why?
|
| Survival Rate | 1 | 2011 | 12786 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2009 | 5096 | 0.010 |
Why?
|
| Venous Thrombosis | 1 | 2006 | 1240 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 18107 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 4848 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 8637 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2007 | 3292 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 1994 | 408 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2004 | 2119 | 0.010 |
Why?
|
| Thrombosis | 1 | 2006 | 2968 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 5854 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 56392 | 0.010 |
Why?
|
| Vasodilation | 1 | 1995 | 944 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1994 | 1525 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 85729 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 9648 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 13273 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 8939 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 213241 | 0.000 |
Why?
|
| Adult | 1 | 2018 | 213889 | 0.000 |
Why?
|
| HIV Infections | 1 | 2009 | 16715 | 0.000 |
Why?
|